Antiretroviral (ARV) Therapy in Resource Poor Countries : What do we Need in Real Life ?

Castelli F, Pietra V, Diallo I, Schumacher RF, Simpore J.

Open AIDS J. 2010 Jan 19 ;4:28-32. doi : 0.2174/1874613601004020028.

PMID : 20148089 [PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/20148089

Abstract

Significant progresses have been made in the last 5 years towards the ultimate goal to provide universal access to care for all HIV/AIDS patients needing antiretroviral treatment in resource-poor countries. However, many barriers are still to be overcome, including () cost of care for the individual, () stigma, () lack of qualified human resources and infrastructure, especially in the rural setting, () rescue drugs for failing patients and () pediatric formulations. Priority actions to be promoted if the fight against HIV/AIDS is to be successful include : (i) promoting access to care in the rural areas, (ii) strengthening of basic health infrastructures, (iii) waiving of users’ fee to get ARV, (iv) a larger variety of drugs, with particular regard to fixed dose combination third line drugs and pediatric formulations, (v) local quality training and (vi) high quality basic and translational research. While the universal access to HIV care is crucial in developing countries, a strong emphasis on prevention should be maintained along.



Université Joseph KI-ZERBO : Soutenance de quatre thèses de doctorat unique (...)

Appel à candidatures pour inscription en Master de Biologie Moléculaire et de (...)

Appel à candidature pour le recrutement d’experts, animateurs d’ateliers de (...)

Code d’Ethique et de Déontologie des Enseignants-chercheurs du Burkina (...)

Copyright LaBioGene 2013 - 2014